ACCS100

DRUG2 trials

Sponsors

Texas Enterosorbents Incorporated, Kenya Medical Research Institute

Conditions

AflatoxicosisDietary Carcinogenesis

Phase 2

Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100

CompletedNCT01677195

Texas Enterosorbents IncorporatedDietary Carcinogenesis

Start: 2012-09-30End: 2014-08-31Updated: 2016-04-19

Evaluation of ACCS100 to Reduce Aflatoxin Exposure in Kenya

CompletedNCT02188953

Kenya Medical Research InstituteAflatoxicosis

Start: 2014-08-31End: 2014-09-30Updated: 2014-09-16